Christian Stief, MD, from Ludwig-Maximilians-University, Munich, Germany discusses developments in prostate cancer presented at a video session at the European…
Browsing: Acute Lymphoblastic Leukemia
Axel Merseburger, from the Schleswig-Holstein University Hospital, Lübeck, Germany, discusses the use of social media in uro-oncology at the European…
Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor…
From our MPN Ask the Expert series, Patient Power viewer, Maryse, asks a question about the MPL mutation and if…
Joaquim Bellmunt, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, summarizes the aims and results of the KEYNOTE-045 (NCT02256436)…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center explains which patients should get endocrine therapy and genomic…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center explains the use of genomic profiling for prognoses in…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center discusses the treatment trends in 2017 for estrogen receptor…
Lee S. Schwartzberg, MD of University of Tennessee Health Science Center discusses current clinical trials and genomic profiling in breast…
Shaji K. Kumar, MD of Mayo Clinic
Shaji K. Kumar, MD of Mayo Clinic gives an overview of the upcoming treatment trends for multiple myeloma, which include…
Shaji K. Kumar, MD of Mayo Clinic discusses how to gain a better understanding in treating multiple myeloma. He states…
Shaji K. Kumar, MD of Mayo Clinic CHANGE TITLE–Myeloma
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School explains whether or not somatostatin analogues were needed to…
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School gives an overview of his discussion, Novel Treatment Options…
Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School discusses the results of the NETTER-1 study, which concluded…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? explains what to do with patients who have neo-adjuvant chemotherapy and…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? stresses the importance of tailoring treatment options to patients’ specific risks.…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? discusses the role for regional nodal irradiation in breast cancer treatment.…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? gives an overview of the new radiation guidelines for treating patients…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? explains how to select effective radiation options for breast cancer treatment.…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? gives an overview of her presentation, “Evolving Radiation Therapy Recommendations for…
Kilian E. Salerno, MD of Roswell Park Cancer Institute? discusses treatment trends in 2017 for breast cancer treatment. She states…
Clifford Goodman, PhD of Lewin Group gives an overview of the types of evidence that the National Comprehensive Cancer Network…
Clifford Goodman, PhD of Lewin Group discusses concerns over patient affordability with cancer care. He argues that the separation between…
Clifford Goodman, PhD of Lewin Group gives an overview of another theme from his session, which was disparities in cancer…
Clifford Goodman, PhD of Lewin Group gives an overview of the National Comprehensive Cancer Network’s (NCCN) guidelines program and the…
Clifford Goodman, PhD of Lewin Group discusses themes of his session, which included concerns over cutbacks for the National Institute…
Clifford Goodman, PhD of Lewin Group discusses concerns about a rollback in coverage, losses in preventive services, and affordability in…
Stephen B. Edge, MD of Roswell Park Cancer Institute gives an overview of the new staging system by the American…
Stephen B. Edge, MD of Roswell Park Cancer Institute discusses questions he received from the audience, one being whether or…
Stephen B. Edge, MD of Roswell Park Cancer Institute gives an overview of his presentation “Implications of the New AJCC…
Stephen B. Edge, MD of Roswell Park Cancer Institute explains how health care disparities have become a critical issue and…
Stephen B. Edge, MD of Roswell Park Cancer Institute discusses the importance of personalized medicine, specifically genomic profiling in breast…
Stephen B. Edge, MD of Roswell Park Cancer Institute discusses the American Joint Committee on Cancer (AJCC) and its collaboration…
Lois Ramondetta, MD of MD Anderson Cancer Center gives an overview of her presentation, HPV Vaccine Champion Training for Gynecologic…
Lois Ramondetta, MD of MD Anderson Cancer Center discusses the importance of communicating the safety and efficacy of the HPV…
Lois Ramondetta, MD of MD Anderson Cancer Center gives an overview of an HPV-related abstract that was discussed at the…
Jennifer Young Pierce, MD of Medical University of South Carolina gives an overview of her presentation, HPV Vaccine Champion Training…
Jennifer Young Pierce, MD of Medical University of South Carolina gives an overview of the practical guidelines for gynecologic oncologists…
Jennifer Young Pierce, MD of Medical University of South Carolina discusses the importance of spreading HPV vaccine awareness, especially the…
Jennifer Young Pierce, MD of Medical University of South Carolina gives an overview of the treatment trends for the HPV…
Elizabeth Swisher, MD of University of Washington Medical Center discusses the treatment trends for ovarian cancer for 2017. She highlights…
Elizabeth Swisher, MD of University of Washington Medical Center explains why it is crucial to use both germline and tumor…
Elizabeth Swisher, MD of University of Washington Medical Center discusses development of more efficient clinical tests that will accurately predict…
Elizabeth Swisher, MD of University of Washington Medical Center gives an overview of a second presentation that discussed the ARIEL2…
Elizabeth Swisher, MD of University of Washington Medical Center discusses her hopes in the ARIEL2 Trial in helping to optimize…
Ruben A. Mesa, MD of Mayo Clinic discusses questions from the audience that were asked during his session on the…
Ruben A. Mesa, MD of Mayo Clinic gives an overview of the upcoming treatment trends for myeloproliferative neoplasms, which include…
Ruben A. Mesa, MD of Mayo Clinic gives an overview of interesting topics, such as health disparities and access to…